Intel beats VLSI in $3.1bn Texas suit

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Intel beats VLSI in $3.1bn Texas suit

adobestock-288834591-editorial-use-only.jpeg

In the second trial of three, Intel punches back at VLSI after a $2.18 billion verdict from the same court in March

In a surprise turn of events at the District Court for the Western District of Texas yesterday, April 21, a jury ruled in favour of Intel in the tech company’s second patent trial against VLSI Technology, in which the latter was seeking $3.1 billion in damages.

The news comes less than two months after a jury in the same court ruled against Intel, delivering a record-breaking $2.18 billion damages award to VLSI, a unit of the hedge fund Fortress Investment Group.

Intel is seeking a new trial in that case, and has said it intends to appeal the $2.18 billion verdict.

Related stories

Yesterday’s ruling, made in Waco, was handed down in the fourth patent trial to take place in Alan Albright’s court since his appointment in 2018 and it was the third victory for a defendant. The first was in MV3 v Roku, which ended in December 2020.

VLSI sued Intel at the Western District of Texas in April 2019, alleging that the tech company had infringed its patent pertaining to speed shift technology.

A third trial in Albright’s court over similar patented technology is scheduled for June.

more from across site and SHARED ros bottom lb

More from across our site

VO, which has offices in the Netherlands, Belgium and Germany, is the second European IP firm to secure external backing this week
The Bardehle Pagenberg attorneys-at-law discuss the firm’s Managing IP EMEA Awards 2026 success, Unified Patent Court litigation strategy, and evolving European patent trends
A patent battle between two legal tech companies and a loss for Elon Musk’s xAI against OpenAI were also among the top talking points
With drug prices a hot topic in the US, courts are seemingly more reluctant to prevent the entry of generics to the market
Academic Eden Sarid joins us during Pride Month to discuss queer expression and IP law, Patagonia v Pattie Gonia, and how queer and AI-generated creations both pose novelty concerns
Patent attorney Michael Henson joins the firm to lead its freshly launched blockchain and digital assets practice
A dispute over mammogram technology, and a development in the case between GSK and Moderna were also among the top talking points in recent weeks
With rankings for Western Europe set to be published on June 25, we sat down with our research lead to find out what practitioners and law firms can expect
Peter O’Sullivan, a professional services executive, says he is looking forward to helping Pearce IP become the leading life sciences firm in Australia and New Zealand
Matteo Di Lernia, advocate at LCA Studio Legale, unpicks the CJEU’s ruling in M.M. Ristorazione v Villa Ramazzini, including its impact on litigation strategies
Gift this article